Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Nexalin Technology logo — Treatments for anxiety and insomnia without medication

Nexalin Technology

Treatments for anxiety and insomnia without medication

Founded 2010 United States Houston, United States 22 employees Post Ipo Equity Total: $5.75M Hardware

General Information

Company Name Nexalin Technology
Founded Year 2010
Location United States Houston, United States +1
Founders / Decision Makers
Team member
Employees 22
Industries Hardware
Funding Stage Post Ipo Equity
Social

Get notified when Nexalin Technology moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nexalin Technology

Nexalin Technology is a U.S.-based startup offering non-invasive and drug-free therapy for anxiety, depression, and insomnia. The company's patented waveform, Transcranial Electrical Stimulation (TES), has shown significant increase in beta-endorphins in clinical trials, demonstrating its efficacy. This technology has received FDA approval and is classified as a non-significant risk device, underlining its safety and reliability. The therapy's long-lasting effects have been attributed to its ability to normalize neurochemistry and influence various neurochemical levels in the brain, including neuropeptides, neurotransmitters, and neuromodulators. Nexalin Technology, established in 2010, operates in the hardware industry and received a $501.71K Venture Round investment in August 2011. The company's focus on leveraging innovative technology to address critical mental health issues offers potential for substantial growth and impact in the healthcare industry. This underscores the significant market potential for non-pharmaceutical treatment alternatives, positioning Nexalin Technology as an attractive investment opportunity in the rapidly evolving mental wellness sector.

Taxonomy: transcranial electrical stimulation, anxiety treatment, insomnia treatment, non-invasive therapy, FDA approved, neurochemistry normalization, depression treatment, neurochemical influence, beta-endorphins, hypothalamus stimulation, brain structure adaptation, non-drug therapy, health technology, clinical trials

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 27 Jun 2024
Venture Round •••••• - 09 Aug 2011

Nexalin Technology Alternatives & Competitors

Nexalin Technology vs
Bottneuro AG
Bottneuro AG Switzerland

Precision medicine for brain health

Convertible Note
12 employees
Health Care, Health and Wellness
Nexalin Technology vs
Sanarus Technologies
Sanarus Technologies United States

Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system....

Series E
9 employees
Health Care, Women's Health
Nexalin Technology vs
NeoSync, Inc.
NeoSync, Inc. United States

Pioneering non-invasive neuromodulation solutions for Central Nervous System disorders, led by seaso...

Series D
4 employees
Information Technology

FAQ About Nexalin Technology

Treatments for anxiety and insomnia without medication
Nexalin Technology was founded in 2010.
Nexalin Technology is headquartered in Houston, United States.
Nexalin Technology operates in the following industries: Hardware.
Nexalin Technology has approximately 22 employees.
Nexalin Technology has completed 2 funding rounds, raising a total of $5.75M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Nexalin Technology include Bottneuro AG, Sanarus Technologies, NeoSync, Inc., SPR Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nexalin Technology and Bottneuro AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nexalin Technology and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy